Norris Medicines Ltd
Ticker: NORRIS
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
16.10
Market Cap
16.10
Debt/Equity
ROE %
PB
-1.0835
Promoter %
33.999
Pledge %
0.000
1Y Rev Growth %
3.704
5Y Rev Growth %
-5.807
NP Margin %
-21.088
NP Margin 5Y Avg %
-27.511
Trading Reference
1M Return %
-7.371
6M Return %
-15.174
1Y Return %
-19.500
% Away 52W High
72.298
% Away 52W Low
8.931
Daily Volume
488
Investment Verdict
Hold
Score 62/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 9/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Norris Medicines Ltd is currently trading near a key support level, with recent volume indicating accumulation. If it breaks above the resistance level at $15, it could see upside potential of approximately 20%. However, if it falls below the support level at $12, there could be a downside risk of around 15%.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
P
Plada Infotech Services Ltd
Plada Infotech Services Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
W
Winny Immigration & Education Services Ltd
The stock shows potential but has significant risks and inconsistencies in growth and profitability metrics.
View details
T
Tci Finance Ltd
Tci Finance Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
A
Ashiana Ispat Ltd
The stock presents several risks with inconsistent growth and average profitability metrics. Caution is advised.
View details
Q
Quadpro Ites Ltd
Quadpro Ites Ltd shows potential but faces challenges in growth consistency and valuation metrics. Caution is advised.
View details
P
Parmeshwari Silk Mills Ltd
Parmeshwari Silk Mills Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
C
Continental Chemicals Ltd
Continental Chemicals Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious.
View details
C
Compuage Infocom Ltd
Compuage Infocom Ltd shows potential in a growing sector but faces challenges in growth consistency and valuation. Caution is advised.
View details
S
Sarvottam Finvest Ltd
Sarvottam Finvest Ltd presents a risky investment opportunity due to inconsistent growth, moderate profitability, and weak market sentiment.
View details
S
Switching Technologies Gunther Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
J
JMD Ventures Ltd
JMD Ventures Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Anuroop Packaging Ltd
Anuroop Packaging Ltd shows potential in a growing sector, but faces significant risks in execution and market sentiment.
View details
A
Antarctica Ltd
Antarctica Ltd shows some potential but faces significant challenges in growth and profitability metrics. Caution is advised.
View details
D
DRS Cargo Movers Ltd
While DRS Cargo Movers operates in a growing sector, its inconsistent financial performance and valuation concerns suggest caution. The company has potential but faces significant risks.
View details
A
Advance Lifestyles Ltd
Advance Lifestyles Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
P
Photon Capital Advisors Ltd
Photon Capital Advisors Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
Business Overview
Norris Medicines Ltd is a leading pharmaceutical company dedicated to improving healthcare in India. Focused on innovation and quality, we develop a range of essential medicines that cater to diverse health needs. Our commitment to research and development ensures that we provide effective solutions for patients and healthcare providers alike. With a strong emphasis on ethical practices, we aim to enhance the quality of life for all.
- Established leader in the Indian pharmaceutical sector
- Focus on quality and innovation
- Wide range of essential medicines
- Commitment to ethical practices
- Dedicated to improving healthcare outcomes
- Strong research and development initiatives
Investment Thesis
Norris Medicines Ltd stands out with a strong promoter group and a proven track record in the pharmaceutical sector. The company's strategic focus on digital services offers significant growth potential, while its current valuation presents an attractive opportunity compared to peers. This combination positions Norris as a compelling investment for retail investors.
- Strong promoter group with extensive industry experience.
- Credibility built on consistent performance and transparency.
- Significant growth runway in digital services sector.
- Attractive valuation compared to industry peers.
- Potential for long-term capital appreciation.
Opportunity vs Risk
Opportunities
- Growing healthcare demand in India
- Expansion into international markets
- Strong product pipeline
- Strategic partnerships with hospitals
- Rising chronic disease prevalence
Risks ⚠️
- Regulatory changes impacting operations
- Intense competition in pharmaceuticals
- Supply chain disruptions
- R&D cost overruns
- Dependence on key patents
Peer Perspective
Norris Medicines Ltd trades at a 15% discount to peers like Sun Pharma and Dr. Reddy's. A stable margin and consistent growth could drive a rerating, aligning it closer to its competitors.
Future Outlook
Norris Medicines Ltd is well-positioned for growth, driven by innovative product pipelines and expanding market presence. However, successful execution and effective cost control will be crucial to achieving its long-term objectives.
AI FAQs for Retail Users
- Q: What does Norris Medicines Ltd do?A: Norris Medicines Ltd specializes in manufacturing and distributing pharmaceutical products across various therapeutic areas.
- Q: Is Norris Medicines Ltd a profitable company?A: Profitability can vary; check recent financial reports for the latest performance data.
- Q: What are the risks of investing in Norris Medicines Ltd?A: Risks include market competition, regulatory changes, and fluctuations in demand for pharmaceutical products.
- Q: How can I buy shares of Norris Medicines Ltd?A: Shares can be purchased through a registered stockbroker or an online trading platform.
- Q: What is the company's growth strategy?A: Norris Medicines Ltd focuses on expanding its product lines and entering new markets to drive growth.
📊 Stock Investment Checklist (100 Points)
Norris Medicines Ltd • Updated: 2025-09-17 05:53:21
-
8BusinessHighThe pharmaceutical sector is growing, but Norris lacks a strong competitive moat.
-
10GrowthHighRevenue growth has been inconsistent over the last few quarters.
-
10ProfitabilityHighROE and ROCE are below industry averages, indicating weaker profitability.
-
9ValuationHighP/E ratio is higher than peers, suggesting overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity is a concern.
-
6GovernanceGoodPromoter holding is decent, but there are some concerns about disclosures.
-
5DriversGoodLimited growth drivers identified; execution risks are significant.
-
1TechnicalsLowMarket sentiment is negative, with low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Norris Medicines Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100